Elevated fractional donor-derived cell-free DNA during subclinical graft injury after liver transplantation
{{output}}
Personalized immunosuppression (IS) promises to improve the balance of necessary control of alloreactivity and dose-dependent adverse effects of long-term IS such as kidney insufficiency, infections, and malignancies. The majority of liver transplantation (LT)... ...
